MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Integrative brain states facilitate the expression of Parkinson’s tremor

    MF. Dirkx, M. Shine, RC. Helmich (Nijmegen, Netherlands)

    Objective: To test the hypothesis that fluctuations in integrative brain states and/or arousal drive spontaneous fluctuations in PD rest tremor. Background: Parkinson’s disease (PD) rest…
  • 2023 International Congress

    Pain in people with multiple system atrophy

    N. Campese, B. Calio´, F. Leys, L. Kaltenbach, G. Göbel, J. Wanschitz, A. Schlager, L. Zamarian, K. Bannister, R. Chaudhuri, A. Schrag, R. Granata, S. Kiechl, W. Poewe, K. Seppi, G. Wenning, A. Fanciulli (Innsbruck, Austria)

    Objective: To estimate prevalence of pain in people with multiple system atrophy (MSA).To estimate prevalence of pain in people with multiple system atrophy (MSA). Background:…
  • 2023 International Congress

    Preoperative Dyskinesia Impacts Postoperative Quality of Life in PD Patients with Subthalamic Deep Brain Stimulation

    J. Einhaus, H. Jergas, V. Stopic, C. Hennen, JN. Petry Schmelzer, JC. Baldermann, V. Visser-Vandewalle, MT. Barbe (Cologne, Germany)

    Objective: To evaluate postoperative quality of life (QoL) depending on the occurrence of dyskinesia during standardized levodopa test in patients with Parkinson’s Disease (PD) undergoing…
  • 2023 International Congress

    Association between fine motor function and brain structure: Findings from the population-based Rhineland Study

    X. Yang, S. Estrada, M. Breteler, N. Aziz (Bonn, Germany)

    Objective: To examine the relation between brain structure and fine motor function across adult lifespan in a large cohort study. Background: Decreased fine motor function…
  • 2023 International Congress

    The efficacy of dopamine agonists or monoamine oxidase type B inhibitors as monotherapy in patients with early Parkinson disease: A network meta-analysis

    CSC. Chuang (Changhua, Taiwan)

    Objective: This study aimed to investigate the effectiveness of dopamine agonists or monoamine oxidase type B inhibitors (MAOB-I) as monotherapy in patients with early Parkinson's…
  • 2023 International Congress

    Association Between Antiepileptic Drugs and Subsequent Parkinson’s Disease in East London

    Q. Zhang, J. Bestwick, R. Dobson, C. Marshall, A. Noyce (London, United Kingdom)

    Objective: To investigate the association between antiepileptic drugs (AEDs) prescription and subsequent Parkinson’s disease (PD). Background: Recent observational studies have highlighted an association between epilepsy…
  • 2023 International Congress

    Reaching kinematics in patients with Spinocerebellar Ataxia Type 12 using a markerless motion tracking system

    ABB. Bayen, SC. Choudhury, SM. Majumdar, PB. Basu, MRB. Baker, SNB. Baker, H. Kumar (KOLKATA, India)

    Objective: In the current study, we compared the kinematics of planar reaching movements between patients with Spinocerebellar Ataxia Type 12 (SCA12) and healthy control using…
  • 2023 International Congress

    Blood NfL can track progression in multiple system atrophy

    V. Chelban, A. Perez-Soriano, C. Wilke, A. Foubert-Samier, N. Vijiaratnam, T. Guo, E. Jabbari, K. Senkevich, B. Laurens, P. Péran, O. Rascol, L. Schöls, C. Kobylecki, M. Hu, J. Rowe, T. Foltynie, N. Wood, A. Heslegrave, H. Zetterberg, M. Bocchetta, J. Rohrer, M. Marti, M. Synofzik, H. Morris, W. Meissner, H. Houlden (London, United Kingdom)

    Objective: To validate the role of NfL for disease progression, severity and subject trial selection in MSA. Neurofilament light (NfL) was explored in this regard though…
  • 2023 International Congress

    Neuroprotective properties of arylpiperazine-sulphonamides in an in vitro model of Parkinson’s disease

    A. Kingslake, V. Soskic, M. Iravani (Hatfield, United Kingdom)

    Objective: To investigate the neuroprotective effects of novel arylpiperazine compounds as measured by viability of SH-SY5Y cells in vitro. Background: Parkinson’s disease (PD) is a…
  • 2023 International Congress

    Istradefylline therapy for PD plus oromandibular dystonia

    NAO. Kanzato, SAT. Mochizuki (Haearu-cho, Okinawa, Japan)

    Objective: To clarify the dopaminergic system link between parkinson's disease (PD) and oromadibular dystonias (OMDy) co-occur, and the effect of istradefylline (IST) therapy. Background: OMDy are…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley